Clinical Trials on Mixed Glioma

Total 3964 results

Trisakti University
Indonesia University; Duke-NUS Graduate Medical School; BioGaia AB

Active, not recruiting

The Effect of Probiotic Lactobacillus Reuteri Prodentis Consumption on Gingival Crevicular Fluid Inflammatory Response and Metagenomic Profiles of Oral Microbiome in Orthodontic Patients.

Healthy Subjects With Fixed Orthodontics

Indonesia
National Cancer Institute (NCI)

Recruiting

A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma

Recurrent WHO Grade 2 Glioma | Recurrent Low Grade Astrocytoma | Refractory Low Grade Astrocytoma | Refractory Low Grade Glioma | Refractory WHO Grade 1 Glioma

United States, Canada
NYU Langone Health
Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Terminated

Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas

neurofibromatosis1 (NF1) | Recurrent or Progressive Optic Pathway Gliomas (OPG) | Recurrent or Progressive Low-grade Glioma

United States
Marcela V. Maus, M.D.,Ph.D.

Recruiting

CARv3-TEAM-E T Cells in Glioblastoma

Glioblastoma | Malignant Glioma | Recurrent Glioblastoma | Recurrent Glioma

United States
Helsinki University Central Hospital
Turku University Hospital; Oulu University Hospital; Kuopio University Hospital; Tampere University Hospital

Completed

ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors

Brainstem Glioma

Finland
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

Glioblastoma | WHO Grade III Glioma | WHO Grade II Glioma

United States
St. Jude Children's Research Hospital

Recruiting

Study of Stored Tumor Samples in Young Patients With Brain Tumors

Brain and Central Nervous System Tumors

United States
Misr University for Science and Technology

Active, not recruiting

Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study

Hyperlipidemia; Mixed

Egypt
Merck Sharp & Dohme LLC

Terminated

Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)

Hypercholesterolemia | Mixed Dyslipidemia
University of Pittsburgh
Amgen

Withdrawn

Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies

Adenoma, Pleomorphic | Mixed Salivary Gland Tumor | Salivary Gland Tumor, Mixed | Syringoma, Chondroid

United States
Arrowhead Pharmaceuticals

Active, not recruiting

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia (ARCHES-2)

Mixed Dyslipidemia

United States, Australia, Canada, New Zealand
IlDong Pharmaceutical Co Ltd

Completed

Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia

Mixed Dyslipidemias

Korea, Republic of
Provident Clinical Research
Reliant Pharmaceuticals

Unknown

An Open-Label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

Mixed Dyslipidemia
National Cancer Institute (NCI)
NRG Oncology

Recruiting

Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Serous Adenocarcinoma | Uterine Corpus Carcinosarcoma

United States, Puerto Rico
University of South Florida
Oticon Medical

Recruiting

Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID)

Hearing Loss, Conductive | Hearing Loss, Mixed | Deafness, Unilateral

United States
Guang'anmen Hospital of China Academy of Chinese...

Recruiting

Translation and Validation of MESA Questionnaire of Chinese Language Version

Mixed Urinary Incontinence | Questionnaire | Urgency-predominant Mixed Urinary Incontinence

China
Cochlear
Analytical Solutions Group, Inc.; R. P. Chiacchierini Consulting, LLC

Completed

Osia 2 Pediatric Expansion Study

Conductive Hearing Loss | Single-Sided Deafness | Mixed Hearing Loss

United States
Medtronic Surgical Technologies

Completed

Ambispective Clinical Evaluation of Sophono™ (ACES)

Conductive Hearing Loss | Single-Sided Deafness | Mixed Hearing Loss

United States
Oticon Medical
Statistiska Konsultgruppen

Completed

Clinical Survey of Oticon Medical Ponto Implants and a Surgical Technique With Tissue Preservation

Conductive Hearing Loss | Single Sided Deafness | Mixed Hearing Loss

Netherlands
Oticon Medical

Completed

Clinical Survey of Oticon Medical Healing Cap

Conductive Hearing Loss | Mixed Hearing Loss | Unilateral Partial Deafness

Denmark
Crystal Mackall, MD
National Institutes of Health (NIH); California Institute for Regenerative... and other collaborators

Recruiting

GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas(DIPG) & Spinal Diffuse Midline Glioma(DMG)

Glioma of Spinal Cord | Glioma of Brainstem

United States
National Cancer Institute (NCI)

Active, not recruiting

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

Glioblastoma | WHO Grade 3 Glioma | Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Glioma | Recurrent Cholangiocarcinoma | WHO Grade 2 Glioma

United States
Oticon Medical

Completed

Clinical Survey of Different Abutment Topologies

Conductive Hearing Loss | Mixed Hearing Loss | Unilateral Partial Deafness

Sweden
University of Miami
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Recruiting

Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) | Mixed Connective Tissue Disease (MCTD)

United States
Oticon Medical

Active, not recruiting

Clinical Investigation Study of Safety and Performance of the Sentio System.

Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, Mixed

Germany, Netherlands, United Kingdom
Oticon Medical

Active, not recruiting

Evaluation of a Hearing Device for Transmitting Sound to the Inner Ear

Conductive Hearing Loss | Mixed Hearing Loss

Sweden
Cochlear

Completed

Osia CPT Code Study

Conductive Hearing Loss | Mixed Hearing Loss

United States
AGO Study Group
Merck Sharp & Dohme LLC

Completed

Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors

Carcinosarcoma | Leiomyosarcoma | Mesenchymal Tumor

Germany
Julie Krystal
Janssen Pharmaceuticals

Recruiting

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

Glioblastoma Multiforme | Gliosarcoma | Anaplastic Astrocytoma | Pleomorphic Xanthoastrocytoma | Pilocytic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Low-grade Glioma | DIPG | Brainstem Glioma | Optic Nerve Glioma | Pilomyxoid Astrocytoma | Glioma, Astrocytic

United States
Children's Hospital Medical Center, Cincinnati
The DIPG Collaborative

Recruiting

International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Diffuse Midline Glioma

United States
St. Joseph's Hospital and Medical Center, Phoenix
Translational Genomics Research Institute

Terminated

Identification of Genomic Changes in Families Having Multiple Members With Tumors

Glioma

United States
Istari Oncology, Inc.
Duke University; Solving Kids' Cancer; The Andrew McDonough B+ Foundation

Completed

Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children

Glioblastoma | Malignant Glioma | Gliosarcoma | Ependymoma | Medulloblastoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Atypical Teratoid/Rhabdoid Tumor of Brain | Pleomorphic Xanthoastrocytoma of Brain | Embryonal Tumor of Brain

United States
National Cancer Institute (NCI)

Completed

Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Adult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Recurrent Adult Brain Neoplasm

United States
Xuanwu Hospital, Beijing
Beijing Mario Biotech Company; Hebei Senlang BIotech Company; Beijing HuiNengAn...

Recruiting

Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas

Glioma | Malignant Glioma of Brain | Recurrence Tumor

China
Duke University
Genentech, Inc.

Completed

Bevacizumab Beyond Progression (BBP) (BBP)

Glioblastoma | Malignant Glioma | Gliosarcoma | Grade 4 Malignant Glioma

United States
Annick Desjardins
Tactical Therapeutics, Inc.

Terminated

Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Malignant Glioma (WHO Grade III or IV)

United States
Annick Desjardins
Tactical Therapeutics, Inc.

Terminated

Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure

Malignant Glioma (WHO Grade III or IV)

United States
Kura Oncology, Inc.

Recruiting

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Advanced Malignant Neoplasm | Mixed Phenotype Acute Leukemia | Mixed Lineage Leukemia | Mixed Lineage Acute Leukemia

United States, Spain, United Kingdom, France, Germany, Canada, Belgium, Italy
National Cancer Institute (NCI)

Active, not recruiting

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia

United States
Alexandria University

Unknown

Accuracy and Reproducibility of Virtually Guided Minimally Invasive Tooth Preparations Using Reverse Engineering

Marginal Adaptation of Fixed Dental Prosthesis

Egypt
Children's Hospital Medical Center, Cincinnati
Novartis

Terminated

A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy

High Grade Glioma | Diffuse Intrinsic Pontine Glioma | Bithalamic High Grade Glioma

United States
Karolinska University Hospital
Celluminova AB

Recruiting

Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem (CeNo2)

Glioma, Malignant

Sweden
King's College Hospital NHS Trust
King's College London

Not yet recruiting

Establishing Radiolabelled PSMA as a Target for Glioma Treatment

Glioma, Malignant

United Kingdom
Mayo Clinic
Brains Together for the Cure

Active, not recruiting

A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas

Malignant Glioma

United States
Hellenic Cooperative Oncology Group

Completed

Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel

Malignant Glioma
Duke University
Duke Cancer Institute

Completed

Early Palliative Care Intervention in Malignant Glioma

Malignant Glioma

United States
Eisai Co., Ltd.

Completed

Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

Malignant Glioma

Japan
AHS Cancer Control Alberta

Completed

Comparative 2-D Tumor Analysis in Familial Gliomas

Malignant Glioma

Canada
AHS Cancer Control Alberta

Completed

Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy

Malignant Glioma

Canada
Sabine Mueller, MD, PhD
Mayo Clinic; Vyriad, Inc.; No More Kids With Cancer; The Matthew Larson Foundation...

Completed

Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT

Medulloblastoma Recurrent | Atypical Teratoid/Rhabdoid Tumor | Medulloblastoma, Childhood, Recurrent

United States

Clinical Trials on Mixed Glioma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations